Synchron announced today that it launched a community-centered registry to evaluate its brain-computer interface (BCI) technology. The company said its study aims to bring patients, carers and clinicians together to learn about BCI design and its benefits for people with limited mobility. Synchron designed its BCI technology to decipher the neural code of the brain, […]
Synchron
BCI developer Synchron buys stake in thin film maker Acquandas
Synchron, a developer of brain-computer interface (BCI) technology, today announced the acquisition of an equity stake in Acquandas. Acquandas, a German-based company, specializes in high-precision components for healthcare and other industries. The company bases its metallic components on state-of-the-art microsystem technology processes. It fabricates thin film components for applications in medical devices, including micro-patterned nitinol […]
BCI developer Synchron names new chief technology officer
Synchron has promoted Riki Banerjee to chief technology officer, replacing co-founder Nick Opie in the role. Opie will remain on the brain-computer interface (BCI) developer’s board of directors, the company said today. Banerjee joined Synchron as VP of R&D in September 2021 after 12 years with Medtronic’s neurovascular operating unit. She will now lead all […]
BCI maker Synchron adds former Dexcom CEO to its board
Brain-computer interface (BCI) developer Synchron announced today that it appointed medtech veteran Andy Rasdal to its board of directors. Rasdal brings more than 30 years of experience in developing and commercializing novel medical devices. He previously served as CEO of Dexcom, a leader in the continuous glucose monitor (CGM) space. There, he led the company […]
Synchron completes patient enrollment in brain-computer interface trial
Synchron announced today that it completed patient enrollment in the COMMAND clinical trial for its brain-computer interface (BCI). The U.S.-based trial operating under FDA investigational device exemption (IDE) enrolled six patients in total. Synchron says it’s the first IDE awarded by the FDA to assess a permanently implanted BCI. The early feasibility study assesses safety […]
Synchron says study backs its brain–computer interface’s safety
Synchron’s stent-like brain-computer interface is getting a boost from new clinical study results out of Australia. JAMA Neurology today published peer-reviewed, long-term safety results involving four people with severe bilateral upper-limb paralysis. Twelve months after having Synchron’s Stentrode implanted inside a blood vessel in the brain, there were no adverse events. In addition, there was […]
The top 10 medtech news trends of 2022
In this episode, your diligent team of DeviceTalkers assembled to review our top 10 medtech news trends. It’s our 2022 Newmarker’s Newsmakers! Executive Editor Chris Newmarker, Pharma Editor Brian Buntz, Managing Editor Jim Hammerand, Senior Editor Danielle Kirsh and Associate Editor Sean Whooley joined me, DeviceTalks Editorial Director Tom Salemi, for the latest DeviceTalks podcast. […]
Synchron raises $75M Series C for BCI with investments from Bill Gates, Jeff Bezos
Synchron announced today that it raised an oversubscribed $75 million Series C financing round for its brain-computer interface (BCI) technology. Gates Frontier (Bill Gates’ investment fund) and Bezos Expeditions (Jeff Bezos’ investment fund) participated in the round. ARCH Venture Partners led the funding. Reliance Digital Health, Greenoaks, Alumni Ventures,Moore Strategic Ventures and Project X also […]
Synchron to begin enrollment at UPMC for brain-computer interface trial
Synchron announced today that it started enrollment in the Command trial for its brain-computer interface (BCI) technology. The company commenced enrollment at the University of Pittsburgh in Pittsburgh, Pennsylvania. It plans for its early feasibility study to primarily assess safety while exploring quantified efficacy measures of the Synchron Stentrode. Synchron’s study, funded by the National […]
7 brain-computer interface companies you need to know
Blackrock Neurotech, BrainGate, ClearPoint Neuro, Neuralink, Synchron and more race to bring brain-computer interface (BCI) tech to market. They’re using a multitude of methods — and developing their own systems that would allow patients to control a computer with their brain. Such technology could potentially enable countless immobile people someday to control a mouse cursor, […]
Report: Elon Musk looks to invest in brain-computer interface competitor Synchron
Reuters is reporting that Elon Musk has approached his Neuralink company’s rival, Synchron, over a potential investment. Musk’s Neuralink recently fell behind Synchron in the brain-computer interface (BCI) space after the latter announced that it completed its first-in-human brain-computer interface (BCI) implant in the U.S. using an endovascular BCI approach, which does not require invasive […]